Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2578881 | Thérapie | 2014 | 7 Pages |
Abstract
Le Centre de référence sur les agents tératogènes (CRAT), founded in 1975, is the first national and international public organization especially involved in the problem of drugs during pregnancy, and during this period of time has been responsible for many initiatives in this field: health care providers information and counsel service, innovating risk assessment methodology, new method for clinical data collection leading to a database including more than 50 000 exposed pregnancies, innovative free access internet website (http://www.lecrat.org), multidisciplinary expert group in French medicines agencies (Afssaps/ANSM) and foundation of a European network “European network teratology information service” (ENTIS). All these innovations represent consequent advances and contribute to a better management of exposed pregnant women and their newborns, as well as the survey and signal detection during pregnancy. The CRAT is also involved in the field of drugs on fertility and on paternal exposures.
Keywords
ABMCRATAMMCrPVAFSSAPSANSMAP-HPIRDIRMDCIHASRCPAMPEMADIUEuropean Medicines agencyAgence française de sécurité sanitaire des produits de santéHaute Autorité de santéMalformationPregnancyGrossesseimagerie par résonnance magnétiqueAllaitementDrugMedicamentANSESLactationautorisation de mise sur le marchéCentre régional de pharmacovigilancedénomination commune internationaleBirth defectNouveau-néNewbornAssistance médicale à la procréation
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology, Toxicology and Pharmaceutics (General)
Authors
Elisabeth Elefant, Catherine Vauzelle, Delphine Beghin,